Search Results - Lars Bullinger

Refine Results
  1. 1

    Chronic lymphocytic leukemia – genomics lead the way by Daniel Mertens, Lars Bullinger, Stephan Stilgenbauer

    Published in Haematologica (2011-10-01)
    Get full text
    Article


  2. 2

    Feasibility and acceptability of an online psychological group intervention for allogeneic hematopoietic stem cell transplantation inpatients by Karl Haller, Asita Behzadi, Johannes C. Ehrenthal, Lars Bullinger, Johann Ahn

    Published in HemaSphere (2025-10-01)
    Get full text
    Article


  3. 3

    Advanced disease and CD8+ TEMRA cells predict severe infections in multiple myeloma by Eva Tranter, David Busch, Clarissa Heck, Igor Wolfgang Blau, Axel Nogai, Phillip Schiele, Phillip Schiele, Christian Meisel, Christian Meisel, Christian Meisel, Lars Bullinger, Lars Bullinger, Lars Bullinger, Marco Frentsch, Marco Frentsch, Il-Kang Na, Il-Kang Na, Il-Kang Na, Il-Kang Na

    Published in Frontiers in Immunology (2025-02-01)
    Get full text
    Article


  4. 4

    Relapse of NPM1-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation by Jan Braune, Kathrin Rieger, Olga Blau, Ulrich Keller, Lars Bullinger, Jan Krönke

    Published in Case Reports in Hematology (2022-01-01)
    Get full text
    Article


  5. 5

    Identifying Prognostic SNPs in Clinical Cohorts: Complementing Univariate Analyses by Resampling and Multivariable Modeling. by Stefanie Hieke, Axel Benner, Richard F Schlenk, Martin Schumacher, Lars Bullinger, Harald Binder

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  6. 6

    Real-world experience with TTFields in glioma patients with emphasis on therapy usage by Claudius Jelgersma, Joan Alsolivany, Gülsüm Akkas, David Wasilewski, David Wasilewski, Bastian Gastl, Martin Misch, David Capper, David Capper, David Kaul, David Kaul, Lars Bullinger, Lars Bullinger, Peter Vajkoczy, Julia Onken, Julia Onken, Julia Onken

    Published in Frontiers in Oncology (2025-01-01)
    Get full text
    Article


  7. 7

    P828: EFFECT OF ANTI-CD38 MONOCLONAL ANTIBODIES ON THE INTERACTION OF MYELOMA CELLS WITH BONE MARROW STROMAL CELLS by Malgorzata Lienhart, Yichen Liu, Ekaterina Slonova, Anna Dolnik, Igor Wolfgang Blau, Axel Nogai, Lars Bullinger, Olga Blau

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  8. 8

    Acute myeloid leukemia with mutated nucleophosmin 1: an immunogenic acute myeloid leukemia subtype and potential candidate for immune checkpoint inhibition by Jochen Greiner, Susanne Hofmann, Michael Schmitt, Marlies Götz, Markus Wiesneth, Hubert Schrezenmeier, Donald Bunjes, Hartmut Döhner, Lars Bullinger

    Published in Haematologica (2017-12-01)
    Get full text
    Article


  9. 9

    Long‐term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls by Nina Winkelmann, Michaela Schwarz, Bert Hildebrandt, Oliver Henke, Lars Bullinger, Il‐Kang Na, Sebastian Stintzing, Philipp le Coutre

    Published in eJHaem (2022-08-01)
    Get full text
    Article


  10. 10

    Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia by Eugen Tausch, William Close, Anna Dolnik, Johannes Bloehdorn, Brenda Chyla, Lars Bullinger, Hartmut Döhner, Daniel Mertens, Stephan Stilgenbauer

    Published in Haematologica (2019-09-01)
    Get full text
    Article


  11. 11

    Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantation by Marie Luise Hütter-Krönke, Adela Neagoie, Igor Wolfgang Blau, Verena Wais, Lam Vuong, Andrea Gantner, Johann Ahn, Olaf Penack, Jacqueline Schnell, Klaus Axel Nogai, Bettina Eberspächer, Maral Saadati, Axel Benner, Lars Bullinger, Lars Bullinger, Hartmut Döhner, Donald Bunjes, Elisa Sala

    Published in Frontiers in Immunology (2023-05-01)
    Get full text
    Article


  12. 12

    HLA-C*04:09N is expressed at the cell surface and triggers peptide-specific T-cell activation by Carlotta Welters, Marthe-Lina Welters, Serena Stadler, Lars Bullinger, Julian Strobel, Holger Hackstein, Arunraj Dhamodaran, Thomas Blankenstein, Leo Hansmann

    Published in Haematologica (2023-09-01)
    Get full text
    Article


  13. 13

    Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival by Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger, Axel Benner, Elke Leupolt, Dirk Winkler, Alexander Kröber, Dirk Kienle, Peter Lichter, Hartmut Döhner

    Published in Haematologica (2007-09-01)
    Get full text
    Article


  14. 14

    High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations by Frank Stegelmann, Lars Bullinger, Martin Griesshammer, Karlheinz Holzmann, Marianne Habdank, Susanne Kuhn, Carmen Maile, Stefanie Schauer, Hartmut Döhner, Konstanze Döhner

    Published in Haematologica (2010-04-01)
    Get full text
    Article


  15. 15

    Widely applicable, extended flow cytometric stem cell enumeration panel for quality control of advanced cellular products by Katy Haussmann, Mathias Streitz, Anna Takvorian, Jana Grund, Zemra Skenderi, Carola Tietze-Bürger, Kamran Movassaghi, Annette Künkele, Agnieszka Blum, Lars Bullinger

    Published in Scientific Reports (2022-10-01)
    Get full text
    Article


  16. 16

    Transcription factor 4 (<i>TCF4</i>) expression predicts clinical outcome in <i>RUNX1</i> mutated and translocated acute myeloid leukemia by Florentien E.M. in't Hout, Mylène Gerritsen, Lars Bullinger, Bert A. van der Reijden, Gerwin Huls, Edo Vellenga, Joop H. Jansen

    Published in Haematologica (2020-06-01)
    Get full text
    Article


  17. 17

    Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base asses... by Anne Dörr, Insa Vogel, Friedrich Wittenbecher, Jörg Westermann, Peter Thuss-Patience, Johann Ahn, Uwe Pelzer, Juliane Hardt, Lars Bullinger, Anne Flörcken

    Published in Palliative Care and Social Practice (2024-06-01)
    Get full text
    Article


  18. 18

    Clonal hematopoiesis of indeterminate potential-related epigenetic age acceleration correlates with clonal hematopoiesis of indeterminate potential clone size in patients with high... by Jasper David Feldkamp, Valentin Max Vetter, Christopher Maximilian Arends, Tonio Johannes Lukas Lang, Lars Bullinger, Frederik Damm, Ilja Demuth, Mareike Frick

    Published in Haematologica (2022-03-01)
    Get full text
    Article


  19. 19

    Gene Expression Profiling Predicts Sensitivity of Chronic Lymphocytic Leukemia Cells to Dasatinib by Tamara J. Blätte, Marcin M. Machnicki, Eliza Glodkowska-Mrowka, Anna Dolnik, Marta Karp, Agnieszka Karczmarczyk, Krzysztof Giannopoulos, Lars Bullinger, Tomasz Stoklosa

    Published in HemaSphere (2021-01-01)
    Get full text
    Article


  20. 20

    Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen by Maximilian Schmutz, Manuela Zucknick, Richard F. Schlenk, Daniel Mertens, Axel Benner, Dieter Weichenhan, Oliver Mücke, Konstanze Döhner, Christoph Plass, Lars Bullinger, Rainer Claus

    Published in Clinical Epigenetics (2023-10-01)
    Get full text
    Article


Search Tools: